JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Lyme disease is the most commonly-reported vector-borne disease in North America. The causative agent, Borrelia burgdorferi is a spirochete bacterium transmitted by Ixodid ticks. Transmission and detection of infection in animal models is optimized by the use of tick feeding, which we describe here.

Streszczenie

Transmission of the etiologic agent of Lyme disease, Borrelia burgdorferi, occurs by the attachment and blood feeding of Ixodes species ticks on mammalian hosts. In nature, this zoonotic bacterial pathogen may use a variety of reservoir hosts, but the white-footed mouse (Peromyscus leucopus) is the primary reservoir for larval and nymphal ticks in North America. Humans are incidental hosts most frequently infected with B. burgdorferi by the bite of ticks in the nymphal stage. B. burgdorferi adapts to its hosts throughout the enzootic cycle, so the ability to explore the functions of these spirochetes and their effects on mammalian hosts requires the use of tick feeding. In addition, the technique of xenodiagnosis (using the natural vector for detection and recovery of an infectious agent) has been useful in studies of cryptic infection. In order to obtain nymphal ticks that harbor B. burgdorferi, ticks are fed live spirochetes in culture through capillary tubes. Two animal models, mice and nonhuman primates, are most commonly used for Lyme disease studies involving tick feeding. We demonstrate the methods by which these ticks can be fed upon, and recovered from animals for either infection or xenodiagnosis.

Wprowadzenie

In 2011, Lyme disease was the 6th most common Nationally Notifiable disease in North America (http://www.cdc.gov/lyme/stats/index.html). B. burgdorferi is a versatile microbe, both genetically and antigenically (reviewed in 1). Its genetic constitution includes a large (>900 kB) chromosome and up to 21 plasmids (12 linear, 9 circular), with plasmid content varying among isolates. Much is to be learned about this spirochete, as over 90% of the plasmid open reading frames are unrelated to any known bacterial sequences 2,3 . B. burgdorferi presents a wide variety of antigens as potential targets of host immunity. However, an untreated infection often persists. The interaction of spirochetes with the tick milieu and the vertebrate host environment necessitates adaptation by B. burgdorferi throughout the infection process. Several plasmid-encoded genes are known to be differentially expressed in response to changes in temperature, pH, cell density and even stage of the tick life cycle 4-8.

The study of B. burgdorferi adaptation throughout its enzootic cycle, and host responses following infection by the natural route relies on the ability to feed ticks on appropriate animal models. Such studies are met with the technical challenges of generating ticks that harbor B. burgdorferi, and ensuring the efficient transmission and/or feeding of ticks on the model host. In addition, the containment and recovery of infected ticks is essential. Among the models used are mice and nonhuman primates, each of which serves as a valuable tool in Lyme disease research. As with the white-footed mouse, which is a natural reservoir host for B. burgdorferi, the laboratory mouse is a highly susceptible host that supports persistent infection by B. burgdorferi 9. Following infection of disease-susceptible mice, such as the C3H strain, the spirochetes disseminate to multiple tissues, including the skin, bladder, muscles, joints and heart. Inflammatory responses to the infection lead to diseased heart and joint tissue. While the spirochetes persist in this host and remain infectious, inflammatory lesions may become intermittent, not unlike the process in humans. The mouse model has thus provided much information on B. burgdorferi-induced pathology, including arthritis and carditis and host immune responses 10-12. From the perspective of the pathogen, certain genes differentially expressed during mammalian infection have been characterized, as have some necessary for transmission from the tick vector 13-21.

Though several animal species have been used to study Lyme disease 22, rhesus macaques most closely mimic the multi-organ character of human disease 23. Unlike other animal models, the breadth of disease manifestations such as erythema migrans, carditis, arthritis, and neuropathy of the peripheral and central nervous systems are observed in macaques. In mice, the reservoir host for B. burgdorferi, disease varies by mouse strain and age 24, while the early and late-disseminated manifestations are uncommon 9. In addition, other rodents, lagomorphs, and canines all fail to exhibit neurological disease from B. burgdorferi infection 25. Importantly, macaques exhibit signs that are characteristic of all three phases of Lyme borreliosis, namely, early-localized, early-disseminated, and late-stage Lyme disease 26-28. Erythema migrans (EM) is thought to occur in 70-80% of human cases 29, and is also seen in rhesus macaques 28,30 . Following infection, the spirochetes disseminate from the site of inoculation to multiple organs. Spirochetal DNA has been detected in skeletal muscles, heart, bladder, peripheral nerve and plexus, as well as in the central nervous system (cerebrum, brainstem and cerebellum, spinal cord, and dura mater) 31.

Tick feeding on mice has been utilized by us and other research teams for propagation of tick colonies, in reservoir competence studies 32-36 and in studies of B. burgdorferi pathogenesis 37-40. This technique has also been used for xenodiagnosis and testing of vaccine efficacy in mice 41-44. We have fed Ixodes ticks on nonhuman primates for model development 28, a study of vaccine efficacy 45, and for xenodiagnosis in the assessment of persistence post-antibiotic treatment 46. Ticks that harbor B. burgdorferi can be maintained in a natural enzootic cycle by feeding larvae on infected mice and using the nymphs for studies, as the spirochetes are transmitted through the life stages. In this report, we instruct on how to generate ticks infected with wild type or mutant B. burgdorferi, using capillary tube-feeding. This can also be accomplished by microinjection 47 and by immersion 48. The purpose of artificial introduction of B. burgdorferi into ticks can be to study mutant strains whose transmissibility is unknown, to generate a group of ticks with a high infection rate, and to reduce potential for error by maintaining a clean and otherwise uninfected tick colony. In addition, we demonstrate tick feeding on mice and nonhuman primates, so as to assure containment and recovery of replete ticks. The use of tick feeding is essential for future studies of immune responses to B. burgdorferi infection, potential Lyme vaccine efficacy, and xenodiagnosis for detection of occult infections.

Protokół

An experimental outline of tick inoculation and feeding upon animals for Lyme disease research is depicted in Figure 1.

1. Inoculating Nymphal Ixodes Ticks with B. burgdorferi Using Capillary Tube-feeding

When performing manipulations with ticks, white lab coats with elastic sleeves, gloves, and disposable bouffant caps are worn.

  1. Our technique is a modified version of that reported by Broadwater et al. 49. Prepare capillary tubes by heating and pulling Pasteur pipets to breaking thinness using a pipet puller. Using forceps and dissecting scope, break the tips to the optimal diameter (about 0.2 mm). A tube standardized to the tick mouthpart size is used as a sizing guide. A face shield should be worn when preparing the pipets.
  2. Grow B. burgdorferi to between 2-8 x 107/ml (mid-log phase) in BSK-H medium (Sigma) containing 6% rabbit serum.
  3. Use nymphal ticks that have been stored at 23 °C for 4-6 weeks post-larval molt. Place ticks onto a small 60 x 15 mm petri dish with double-sided tape on the outer bottom surface of the dish. Place the ticks ventral-side facing up.
  4. Dip the capillary tube tip into the B. burgdorferi culture tube after mixing. Place the capillary tube over the hypostome of the tick mouth parts using a dissecting scope. Use molding clay to fix the tube in place, as shown in Figure 2A.
  5. Place the petri dishes with affixed ticks inside a large clear plastic tub for an added level of containment. Wet paper towels are added to provide moisture. Place the ticks in a 37 °C thermal incubator for 30 min-2 hr until defecation is apparent. This indicates that the media containing spirochetes has passed through the tick.
  6. Rest the ticks for 2-4 weeks at 23 °C to allow adaptation to the tick environment before feeding them on animals.

2. Infecting Mice with B. burgdorferi by Tick

  1. Dilute ketamine stock 1:10 in sterile water. Anesthetize each mouse with 100 mg/kg of ketamine by intraperitoneal injection with a tuberculin syringe
  2. Once the mouse is fully anesthetized, shave the mouse from the ears to the middle back using a fine (Remington smooth & silky) electric trimmer.
  3. In a white pan with no other objects nearby, transfer the nymphal ticks (that harbor B. burgdorferi) by a moistened paintbrush to the hairless area of the mouse. Alternatively, uninfected ticks can be placed on mice for xenodiagnosis of mice with suspect infection. The use of a clean, white surface for tick placement helps to ensure that any unattached ticks will be readily seen.
  4. Place the mouse in specialized caging (Allentown Caging, Allentown, PA). The caging consists of a stainless steel grill elevated from the bottom of the cage. The cage top was modified by our in-house machine shop to elevate the water bottle holder enough to allow free movement of the mouse underneath. The pan is filled with about ½ inch of water to trap any ticks that fall off mice (Figure 3A). To minimize the risk of hypothermia, reusable heating pads, microwaved prior to use, are placed underneath the cages until mice wake completely from anesthesia. Animals are often ataxic as they recover from anesthesia and rub against food and water trays, so these must be removed. The water level is low enough to prevent limbs of mice from submersion.
  5. Place the cage inside a tray that has been lined with Tangle trap paste (Contech, Victoria, BC, Canada) and tape to ensure the entrapment of arthropods. Mice are caged singly and observed continuously during the period of anesthesia.
  6. Within 2 hr, when mice are completely awake from the anesthesia, the food tray and water bottle are replaced to the cage. After 24 hr, the housing enrichment consisting of a plastic hut and nylabone is replaced.
  7. After 3, 4, and 5 days, check the mouse, cage and cage water for fed ticks. The cage water is sifted through a white metal pan (i.e. "panning for gold"). Rinse fed ticks in clean water and store in plastic jars (Figure 3B). On days 3 and 4, replace water in cage with clean water. On day 5, check not only the cage, but the mouse thoroughly for ticks. Usually by this point all ticks have fed and the mice can be returned to regular caging.
  8. Place all waste from the mouse cages, including liquids, in biohazard containers for autoclaving and disposal. Keep a log of the number of ticks placed on mice and those recovered at all times.

3. Feeding Ticks on Nonhuman Primates for Infection with B. burgdorferi or xenodiagnosis

  1. Prepare the tick containment device: Cut a 1 ¾ inch diameter circle in the 3 inch x 3 inch LeFlap (flap) using a clean scalpel and the measurement guide. Use the cut-out as a template to cut circles of identical size in the Biatane foam and Duoderm. The foam is used to elevate flap over the surface of the skin and prevent possible crushing of tick. The Duoderm adds another layer of cushioning and overlays the edges of the containment device for added security from tick escape. A diagram of the containment device is depicted in Figure 4.
  2. Veterinary staff will anesthetize the animal with 5-8 mg/kg Telazol by intramuscular injection.
  3. Clip the hair of the animal using electric trimmer (Oster) equipped with size 40 blades. All areas that will be covered by the jacket are clipped: back, front, upper arms. Using shaving cream and dual-blade disposable razors, closely shave an area of approximately 25 cm vertical x 20 cm horizontal. Wipe clean with moist paper towels and blow dry with low heat to dry the skin.
  4. Place the flap on the animal's dorsum, just below the scapula, on either side of the spine. Use a marker to trace the circle in that spot. Prepare the area of skin around the circle by wiping it with SkinPrep. This removes oil in skin that could affect adhesion of glue and containment devices. Leaving about a 1 cm circumference of space around the circle, apply a layer of skin glue (SkinBond) with a width of ~4 cm.
  5. Remove the adhesive backing from the Biatane foam and affix to the skin in the appropriate spot. Animals are again anesthetized by veterinary staff with 5 mg/kg Telazol. Seal the edges with skin glue and Hypafix tape. Remove the adhesive backing from the flap and affix on top of the Biatane. Place Hypafix tape around the edges of the LeFlap, then tape down the mesh flap of the flap and place the jacket on the animal. Tape and Tangle Trap paste is applied to the floor in a perimeter surrounding the nonhuman primate caging for added security.
  6. To minimize the effects of chemicals used in Step 3.4 on tick feeding, the ticks are added 24 hr after the containment device is in place. At this point, the security of the device is also inspected and reinforced if needed. Typically, 20 unfed nymphs (4-8 weeks post-larval molt) are added to the skin within the device using a paintbrush.
  7. Remove the adhesive backing from the mesh of the flap and seal it in place. Lastly, remove the Duoderm backing to expose adhesive, and place on top of the containment device. Add a piece of Hypafix tape across the open mesh circle, and replace the jacket. The completed containment device is shown in Figure 5A.
  8. After 5 days, anesthetize the animals as above and the jackets are removed. Remove the tape first to inspect tick feeding through the mesh (Figure 5B). Carefully peel the Duoderm away from the flap.
  9. Pull back the mesh portion at the edges to provide access to the ticks. Fed ticks are frequently found near or under the foam circle (Figure 5C) and are removed and placed in clean water with a paintbrush. Remove the device once all visible fed ticks are collected (Figure 5D).

Note: Oftentimes, the containment device can simply be peeled away from the skin. If adhesion is strong and could potentially damage the skin, Unisolve solvent is applied to the area for gentle removal. The skin is wiped with isopropanol and ticks are stored at 23 °C. If used for infection, the ticks can be crushed to confirm the number that contained B. burgdorferi. If used for xenodiagnosis, the ticks are kept for 1-3 weeks prior to analysis of midgut contents.

Wyniki

Following the completion of capillary feeding, the ticks are typically rested at 23 °C for 2-3 weeks before they are fed on animals for transmission. Using the capillary-feeding technique, we have found that over 90% of the fed ticks harbor B. burgdorferi. The percentage of positive ticks is determined by washing ticks in peroxide and ethanol, then crushing them in sterile PBS with a microfuge tube-shaped pestle. The midgut contents spilled into the PBS are fixed on slides and stained with an anti-Borrel...

Dyskusje

In order to obtain ticks that harbor B. burgdorferi for downstream studies, the ticks can be: (1) fed on infected mice at the larval stage; (2) immersed in B. burgdorferi cultures at either the larval or nymphal stage 48; (3) microinjected with B. burgdorferi 47; or (4) capillary tube-fed B. burgdorferi 49. While each of these methods has its purpose, for ensuring that a large portion of the ticks to be used for infection harbor B. burgdorferi,...

Ujawnienia

The authors declare that they have no competing financial interests.

Podziękowania

The authors wish to thank Nicole Hasenkampf and Amanda Tardo for technical support. We also thank Drs. Linden Hu and Adriana Marques for recommendation of the LeFlap containment device, and Dr. Lise Gern for instruction on the capillary feeding method. This work was supported by NIH/NCRR Grant 8 P20 GM103458-09 (MEE) and by the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through grant P51OD011104/P51RR000164.

Materiały

NameCompanyCatalog NumberComments
Reagent
BSK-HSigmaB-8291
Ketamine HCl
Tangle Trap coating PasteLadd researchT-131
SkinPrepAllegro Medical Supplies177364
LeFlap, 3" x 3"Monarch Labs
Hypafix tapeAllegro Medical Supplies191523
SkinBondAllegro Medical Supplies554536
UniSolveAllegro Medical Supplies176640
Biatane Foam, adhesive 4"x4"Coloplast3420
DuoDerm CGF Dressing - 4" x 4", (3/4)" adhesive border Convatec187971
Nonhuman primate jackets with flexible 2" back panels; add drawstrings at top and bottomLomir Biomedical Inc.
EQUIPMENT
Pipet pullerDavid Kopf InstrumentsModel 700C
Dark field microscopeLeitz WetzlarDialux
Dissecting microscopeLeicaZoom 2000
Mouse cagingAllentown caging

Odniesienia

  1. Porcella, S. F., Schwan, T. G. Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. Journal of Clinical Investigation. 107, 651-656 (2001).
  2. Fraser, C. M., et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature. 390, 580-586 (1997).
  3. Casjens, S., et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Molecular Microbiology. 35, 490-516 (2000).
  4. Carroll, J. A., Garon, C. F., Schwan, T. G. Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infection & Immunity. 67, 3181-3187 (1999).
  5. Gilmore, R. D., Mbow, M. L., Stevenson, B. Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis. Microbes & Infection. 3, 799-808 (2001).
  6. Ramamoorthy, R., Philipp, M. T. Differential expression of Borrelia burgdorferi proteins during growth in vitro. Infection & Immunity. 66, 5119-5124 (1998).
  7. Ramamoorthy, R., Scholl-Meeker, D. Borrelia burgdorferi proteins whose expression is similarly affected by culture temperature and pH. Infection & Immunity. 69, 2739-2742 (2001).
  8. Schwan, T. G., Piesman, J. Temporal Changes in Outer Surface Proteins A and C of the Lyme Disease-Associated Spirochete, Borrelia burgdorferi, during the Chain of Infection in Ticks and Mice. J. Clin. Microbiol. 38, 382-388 (2000).
  9. Barthold, S. W., de Souza, M. S., Janotka, J. L., Smith, A. L., Persing, D. H. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143, 959-971 (1993).
  10. Barthold, S. W., de Souza, M. Exacerbation of Lyme arthritis in beige mice. Journal of Infectious Diseases. 172, 778-784 (1995).
  11. Barthold, S. W., Feng, S., Bockenstedt, L. K., Fikrig, E., Feen, K. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin. Infect. Dis. 25, S9-S17 (1997).
  12. Miller, J. C., Ma, Y., Crandall, H., Wang, X., Weis, J. J. Gene expression profiling provides insights into the pathways involved in inflammatory arthritis development: Murine model of Lyme disease. Experimental and Molecular Pathology. 85, 20-27 (2008).
  13. Purser, J. E., Norris, S. J. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proceedings of the National Academy of Sciences of the United States of America. 97, 13865-13870 (2000).
  14. Grimm, D., et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proceedings of the National Academy of Sciences of the United States of America. 101, 3142-3147 (2004).
  15. Zhang, J. R., Norris, S. J. Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infection & Immunity. 66 (1), 3689-3697 (1999).
  16. Hodzic, E., Feng, S., Freet, K. J., Borjesson, D. L., Barthold, S. W. Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Infection & Immunity. 70, 3382-3388 (2002).
  17. Hodzic, E., Feng, S., Freet, K. J., Barthold, S. W. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infection & Immunity. 71, 5042-5055 (2003).
  18. Liang, F. T., Nelson, F. K., Fikrig, E. Molecular adaptation of Borrelia burgdorferi in the murine host. Journal of Experimental Medicine. 196, 275-280 (2002).
  19. Samuels, D. S. Gene Regulation in Borrelia burgdorferi. Annual Review of Microbiology. 65, 479-499 (1146).
  20. Gilmore, R. D., et al. The bba64 gene of Borrelia burgdorferi, the Lyme disease agent, is critical for mammalian infection via tick bite transmission. Proceedings of the National Academy of Sciences. 107, 7515-7520 (2010).
  21. Fisher, M. A., et al. Borrelia burgdorferi σ54 is required for mammalian infection and vector transmission but not for tick colonization. Proceedings of the National Academy of Sciences of the United States of America. 102, 5162-5167 (2005).
  22. Barthold, S. W. Animal models for Lyme disease. Laboratory Investigation. 72, 127-130 (1995).
  23. Pachner, A. R. Early disseminated Lyme disease: Lyme meningitis. American Journal of Medicine. 98, 30S-37S (1995).
  24. Barthold, S. W., Beck, D. S., Hansen, G. M., Terwilliger, G. A., Moody, K. D. Lyme Borreliosis in Selected Strains and Ages of Laboratory Mice. Journal of Infectious Diseases. 162, 133-138 (1990).
  25. Philipp, M. T., Johnson, B. J. Animal models of Lyme disease: pathogenesis and immunoprophylaxis. Trends in Microbiology. 2, 431-437 (1994).
  26. Roberts, E. D., et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. Journal of Infectious Diseases. 178, 722-732 (1998).
  27. Roberts, E. D., et al. Chronic lyme disease in the rhesus monkey. Laboratory Investigation. 72, 146-160 (1995).
  28. Philipp, M. T., et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infection & Immunity. 61, 3047-3059 (1993).
  29. Steere, A. C., Sikand, V. K., 348, T. r. e. a. t. m. e. n. t. .. N. .. E. n. g. l. .. J. .. M. e. d. .. The Presenting Manifestations of Lyme Disease and the Outcomes of Treatment. N. Engl. J. Med. 348, 2472-2474 (2003).
  30. Pachner, A. R., Delaney, E., O'Neill, T., Major, E. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology. 45, 165-172 (1995).
  31. Cadavid, D., O'Neill, T., Schaefer, H., Pachner, A. R. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease. Laboratory Investigation. 80, 1043-1054 (2000).
  32. Mather, T. N., Wilson, M. L., Moore, S. I., Ribiero, J. M. C., Spielman, A. Comparing the Relative Potential of Rodents as Reservoirs of the Lyme Disease Spirochete (Borrelia Burgdorferi).. American Journal of Epidemiology. 130, 143-150 (1989).
  33. Mather, T. N., Telford, S. R., Moore, S. I., Spielman, A. Borrelia burgdorferi and Babesia microti: Efficiency of transmission from reservoirs to vector ticks (Ixodes dammini). Experimental Parasitology. 70 (90), 55-61 (1990).
  34. Telford, S. R., Mather, T. N., Adler, G. H., Spielman, A. Short-tailed shrews as reservoirs of the agents of Lyme disease and human babesiosis. Journal of Parasitology. 76, 681-683 (1990).
  35. Mather, T. N., Fish, D., Coughlin, R. T. Competence of dogs as reservoirs for Lyme disease spirochetes (Borrelia burgdorferi). J. Am. Vet. Med. Assoc. 205, 186-188 (1994).
  36. Telford, S. R., Mather, T. N., Moore, S. I., Wilson, M. L., Spielman, A. Incompetence of deer as reservoirs of the Lyme disease spirochete. Am. J. Trop. Med. Hyg. 39, 105-109 (1988).
  37. Lin, T., et al. Analysis of an Ordered, Comprehensive STM Mutant Library in Infectious Borrelia burgdorferi: Insights into the Genes Required for Mouse Infectivity. PLoS ONE. 7, e47532 (2012).
  38. Lin, T., et al. Central Role of the Holliday Junction Helicase RuvAB in vlsE Recombination and Infectivity of Borrelia burgdorferi. PLoS Pathog. 5, e1000679 (2009).
  39. Jacobs, M. B., Norris, S. J., Phillippi-Falkenstein, K. M., Philipp, M. T. Infectivity of the Highly Transformable BBE02- lp56- Mutant of Borrelia burgdorferi, the Lyme Disease Spirochete, via Ticks. Infection and Immunity. 74, 3678-3681 (2006).
  40. Jacobs, M. B., Purcell, J. E., Philipp, M. T. Ixodes scapularis ticks (Acari: Ixodidae) from Louisiana are competent to transmit Borrelia burgdorferi, the agent of Lyme borreliosis. J. Med. Entomol. 40, 964-967 (2003).
  41. Bockenstedt, L., Mao, J., Hodzic, E., Barthold, S., Fish, D. Detection of Attenuated, Noninfectious Spirochetes in Borrelia burgdorferi-Infected Mice after Antibiotic Treatment. The Journal of Infectious Diseases. 186, 1430-1437 (2002).
  42. Barthold, S. W., et al. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrobial Agents & Chemotherapy. 54, 643-651 (2010).
  43. de Silva, A. M., Telford, S. R., Brunet, L. R., Barthold, S. W., Fikrig, E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. Journal of Experimental Medicine. 183, 271-275 (1996).
  44. Fikrig, E., et al. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. Journal of Experimental Medicine. 181, 215-221 (1995).
  45. Philipp, M. T., et al. The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine. 15, 1872-1887 (1997).
  46. Embers, M. E., et al. Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection. PLoS ONE. 7, e29914 (2012).
  47. Kariu, T., Coleman, A. S., Anderson, J. F., Pal, U. Methods for Rapid Transfer and Localization of Lyme Disease Pathogens Within the Tick Gut. J. Vis. Exp. , e2544 (2011).
  48. Policastro, P. F., Schwan, T. G. Experimental infection of Ixodes scapularis larvae (Acari: Ixodidae) by immersion in low passage cultures of Borrelia burgdorferi. J. Med. Entomol. 40, 364-370 (2003).
  49. Broadwater, A. H., Sonenshine, D. E., Hynes, W. L., Ceraul, S., de Silva, A. M. Glass Capillary Tube Feeding: A Method for Infecting Nymphal Ixodes scapularis (Acari: Ixodidae) with The Lyme Disease Spirochete Borrelia burgdorferi. Journal of Medical Entomology. 39, 285-292 (2002).
  50. Hodzic, E., Feng, S., Holden, K., Freet, K. J., Barthold, S. W. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother. 52, 1728-1736 (2008).
  51. Bockenstedt, L. K., Mao, J., Hodzic, E., Barthold, S. W., Fish, D. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. Journal of Infectious Diseases. 186, 1430-1437 (2002).
  52. Schwan, T. G., Burgdorfer, W., Garon, C. F. Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infection and Immunity. 56, 1831-1836 (1988).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Keywords Tick FeedingLyme DiseaseBorrelia BurgdorferiIxodes TicksZoonotic PathogenReservoir HostsWhite footed MousePeromyscus LeucopusNymphal TicksXenodiagnosisMammalian HostsSpirochetesAnimal ModelsMiceNonhuman Primates

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone